Preparation and characterization of novel anti-inflammatory biological agents based on piroxicam-loaded poly-ε-caprolactone nano-particles for sustained NSAID delivery.

Author: AbedelahiAli, AkbarzadehAbolfazl, AlihemmatiAlireza, DavaranSoodabeh, MontaseriAzadeh, Rahmani Del BakhshayeshAzizeh, Tayefi NasrabadiHamid

Paper Details 
Original Abstract of the Article :
Piroxicam (PX), a main member of non-steroidal anti-inflammatory drugs (NSAIDs), is mainly used orally, which causes side effects of the gastrointestinal tract. It also has systemic effects when administered intramuscularly. Intra-articular (IA) delivery and encapsulation of PX in biodegradable poly...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034065/

データ提供:米国国立医学図書館(NLM)

Piroxicam-Loaded Nanoparticles: A Novel Anti-Inflammatory Approach

The quest for effective and safe anti-inflammatory therapies continues, much like a camel searching for a source of water in the vast expanse of the desert. This study explored the potential of piroxicam (PX)-loaded poly-ε-caprolactone (PCL) nanoparticles (NPs) as a novel approach to deliver this non-steroidal anti-inflammatory drug (NSAID). The researchers aimed to develop a new type of bio-agent containing collagen and PX-loaded NPs that could offer advantages over conventional oral delivery, such as sustained release and reduced gastrointestinal side effects. They successfully encapsulated PX in PCL NPs using an oil-in-water (o/w) emulsion solvent evaporation method, resulting in nanoparticles with an average size of 102.7 ± 19.37 nm and an encapsulation efficiency of 92.83 ± 0.4410.

Targeting the Source: A Novel Delivery Method for Arthritis Treatment

The study demonstrated that the PX-loaded PCL NPs, along with collagen, exhibited excellent biocompatibility and exhibited no toxic effects on cells. The findings suggest that these NPs can be a promising delivery system for intra-articular (IA) administration in the treatment of arthritis, providing a targeted approach for drug delivery directly to the affected joint.

A Glimpse into the Future of Anti-Inflammatory Therapies

This study offers a beacon of hope in the desert of inflammatory diseases, paving the way for the development of more effective and targeted anti-inflammatory therapies. The use of nanoparticles for drug delivery represents a promising frontier in medical research, with the potential to revolutionize the treatment of various inflammatory conditions.

Dr.Camel's Conclusion

This innovative research, like a camel carrying precious water across the desert, brings hope to those suffering from inflammatory diseases. By leveraging the power of nanotechnology, this study opens up new avenues for effective and targeted treatment options, potentially improving the lives of millions around the world.

Date :
  1. Date Completed 2020-11-24
  2. Date Revised 2021-04-23
Further Info :

Pubmed ID

32009480

DOI: Digital Object Identifier

PMC7034065

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.